Cargando…

Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol

PURPOSE: Perioperative chemotherapy with FLOT constitutes a standard of care approach for locally advanced, resectable gastric or gastro-esophageal junction (GEJ) cancer. We aimed at investigating anthropometric, CT-based and FDG-PET-based body composition parameters and dynamics during this multidi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huemer, Florian, Hecht, Stefan, Scharinger, Bernhard, Schlintl, Verena, Rinnerthaler, Gabriel, Schlick, Konstantin, Heregger, Ronald, Melchardt, Thomas, Wimmer, Angela, Mühlbacher, Iris, Koch, Oliver Owen, Neureiter, Daniel, Klieser, Eckhard, Seyedinia, Sara, Beheshti, Mohsen, Greil, Richard, Weiss, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314876/
https://www.ncbi.nlm.nih.gov/pubmed/35864270
http://dx.doi.org/10.1007/s00432-022-04096-w
_version_ 1785067401122938880
author Huemer, Florian
Hecht, Stefan
Scharinger, Bernhard
Schlintl, Verena
Rinnerthaler, Gabriel
Schlick, Konstantin
Heregger, Ronald
Melchardt, Thomas
Wimmer, Angela
Mühlbacher, Iris
Koch, Oliver Owen
Neureiter, Daniel
Klieser, Eckhard
Seyedinia, Sara
Beheshti, Mohsen
Greil, Richard
Weiss, Lukas
author_facet Huemer, Florian
Hecht, Stefan
Scharinger, Bernhard
Schlintl, Verena
Rinnerthaler, Gabriel
Schlick, Konstantin
Heregger, Ronald
Melchardt, Thomas
Wimmer, Angela
Mühlbacher, Iris
Koch, Oliver Owen
Neureiter, Daniel
Klieser, Eckhard
Seyedinia, Sara
Beheshti, Mohsen
Greil, Richard
Weiss, Lukas
author_sort Huemer, Florian
collection PubMed
description PURPOSE: Perioperative chemotherapy with FLOT constitutes a standard of care approach for locally advanced, resectable gastric or gastro-esophageal junction (GEJ) cancer. We aimed at investigating anthropometric, CT-based and FDG-PET-based body composition parameters and dynamics during this multidisciplinary approach and the impact on clinical outcomes. METHODS: This retrospective, single-center study was based on medical records and (FDG-PET)-CT images among gastric/GEJ cancer patients undergoing perioperative FLOT chemotherapy. RESULTS: Between 2016 and 2021, 46 gastric/GEJ cancer patients started perioperative FLOT at our tertiary cancer center (Salzburg, Austria). At a median follow-up of 32 months median PFS was 47.4 months and median OS was not reached. The skeletal muscle index (SMI, cm(2)/m(2)) turned out to be the only body composition parameter with a statistically significant decrease during pre-operative FLOT (51.3 versus 48.8 cm(2)/m(2), p = 0.02). Neither pre-FLOT body mass index (BMI), nor SMI had an impact on the duration of pre-operative FLOT, the time interval from pre-operative FLOT initiation to surgery, the necessity of pre-operative or post-operative FLOT de-escalation or the likelihood of the start of postoperative chemotherapy. Pre-FLOT BMI (overweight versus normal, HR: 0.11, 95% CI: 0.02–0.65, p = 0.02) and pre-FLOT SMI (sarcopenia versus no sarcopenia, HR: 5.08, 95% CI: 1.27–20.31, p = 0.02) were statistically significantly associated with PFS in the multivariable analysis. CONCLUSION: The statistically significant SMI loss during pre-operative FLOT and the meaningful impact of baseline SMI and BMI on PFS argue for the implementation of a nutritional screening and support program prior to the initiation of pre-operative FLOT in clinical routine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-022-04096-w.
format Online
Article
Text
id pubmed-10314876
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103148762023-07-03 Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol Huemer, Florian Hecht, Stefan Scharinger, Bernhard Schlintl, Verena Rinnerthaler, Gabriel Schlick, Konstantin Heregger, Ronald Melchardt, Thomas Wimmer, Angela Mühlbacher, Iris Koch, Oliver Owen Neureiter, Daniel Klieser, Eckhard Seyedinia, Sara Beheshti, Mohsen Greil, Richard Weiss, Lukas J Cancer Res Clin Oncol Research PURPOSE: Perioperative chemotherapy with FLOT constitutes a standard of care approach for locally advanced, resectable gastric or gastro-esophageal junction (GEJ) cancer. We aimed at investigating anthropometric, CT-based and FDG-PET-based body composition parameters and dynamics during this multidisciplinary approach and the impact on clinical outcomes. METHODS: This retrospective, single-center study was based on medical records and (FDG-PET)-CT images among gastric/GEJ cancer patients undergoing perioperative FLOT chemotherapy. RESULTS: Between 2016 and 2021, 46 gastric/GEJ cancer patients started perioperative FLOT at our tertiary cancer center (Salzburg, Austria). At a median follow-up of 32 months median PFS was 47.4 months and median OS was not reached. The skeletal muscle index (SMI, cm(2)/m(2)) turned out to be the only body composition parameter with a statistically significant decrease during pre-operative FLOT (51.3 versus 48.8 cm(2)/m(2), p = 0.02). Neither pre-FLOT body mass index (BMI), nor SMI had an impact on the duration of pre-operative FLOT, the time interval from pre-operative FLOT initiation to surgery, the necessity of pre-operative or post-operative FLOT de-escalation or the likelihood of the start of postoperative chemotherapy. Pre-FLOT BMI (overweight versus normal, HR: 0.11, 95% CI: 0.02–0.65, p = 0.02) and pre-FLOT SMI (sarcopenia versus no sarcopenia, HR: 5.08, 95% CI: 1.27–20.31, p = 0.02) were statistically significantly associated with PFS in the multivariable analysis. CONCLUSION: The statistically significant SMI loss during pre-operative FLOT and the meaningful impact of baseline SMI and BMI on PFS argue for the implementation of a nutritional screening and support program prior to the initiation of pre-operative FLOT in clinical routine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-022-04096-w. Springer Berlin Heidelberg 2022-07-21 2023 /pmc/articles/PMC10314876/ /pubmed/35864270 http://dx.doi.org/10.1007/s00432-022-04096-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Huemer, Florian
Hecht, Stefan
Scharinger, Bernhard
Schlintl, Verena
Rinnerthaler, Gabriel
Schlick, Konstantin
Heregger, Ronald
Melchardt, Thomas
Wimmer, Angela
Mühlbacher, Iris
Koch, Oliver Owen
Neureiter, Daniel
Klieser, Eckhard
Seyedinia, Sara
Beheshti, Mohsen
Greil, Richard
Weiss, Lukas
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
title Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
title_full Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
title_fullStr Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
title_full_unstemmed Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
title_short Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
title_sort body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the flot protocol
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314876/
https://www.ncbi.nlm.nih.gov/pubmed/35864270
http://dx.doi.org/10.1007/s00432-022-04096-w
work_keys_str_mv AT huemerflorian bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT hechtstefan bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT scharingerbernhard bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT schlintlverena bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT rinnerthalergabriel bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT schlickkonstantin bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT hereggerronald bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT melchardtthomas bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT wimmerangela bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT muhlbacheriris bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT kocholiverowen bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT neureiterdaniel bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT kliesereckhard bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT seyediniasara bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT beheshtimohsen bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT greilrichard bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol
AT weisslukas bodycompositiondynamicsandimpactonclinicaloutcomeingastricandgastroesophagealjunctioncancerpatientsundergoingperioperativechemotherapywiththeflotprotocol